Lung Cancer Study Group
N E W S – F I L E
As part of the webinar “Lung Cancer: together for a more promising future”, a group of representatives from the Portuguese Pneumology Society (Prof. Dr. António Morais), from the Lung Cancer Study Group (Dr. Teresa Almodovar), from the Portuguese League Against…
On May 18, to mark the European Oncology Nursing Day, the Lung Cancer Study Group (GECP) and the Portuguese Oncology Nursing Association (AEOP) launched a tribute campaign to all oncologist nurses. To celebrate this date, we invited three nurses to…
The Hotel Vila Galé, in Coimbra, will host a meeting organized jointly by the Lung Cancer Study Group (GECP) and the Respiratory Diseases Study Group (GRESP) of the Portuguese Association of General and Family Medicine (APMGF), with support of the…
After the recent opening of two Early Access Programs (PAP) to tepotinib and amivantamab (see news here!) for the treatment of two subtypes of lung cancer, INFARMED granted the request for a PAP to nivolumab in combination with ipilimumab for…
Did you know that today, Thursday, April 7, is World Health Day? This year, to mark this date, the Lung Cancer Study Group will publish a digital campaign with tips to take care of lung health… and beyond! Accept the…
Recently, INFARMED opened two new Early Access to Medicines Programs (PAP) for the treatment of lung cancer, which allow access to innovative therapies in two subtypes: the insertion of exon 20 of the EGFR and the skipping of exon 14…
Next March 31 at 6 pm Pulmonale will hold another webinar, on the theme “The Importance of Early Diagnosis of Lung Cancer” In a dialogue moderated by journalist Vera Arreigoso, Dr. Barbara Parente and Dr. Fernanda Estevinho will be chatting…
Yesterday, March 19th, the Spring Meeting took place, aimed at GECP members. The chosen location was the Montebelo Vista Alegre Ílhavo Hotel. We appreciate everyone’s strong turnout, we had a full room and a very participatory audience. Very soon, we…
Yesterday, the Fronteiras XXI program (which results from a partnership between the Francisco Manuel dos Santos Foundation and RTP) took place, dedicated to “Cancer: When will it be cured?”, which was attended by several specialists in the area, among which…
The Journal of the Lung Cancer Study Group, Vol. XVIII, nº2 of 2021, is now available for consultation and free download here! “New challenges” is the title of the article by Dr. Paulo Costa, a member of the GECP Board,…
Do you know what a clinical trial is and what are the benefits of this type of study? Are you aware of Portugal’s participation in clinical trials in the area of lung cancer? We spoke with Dr. Fernanda Estevinho, oncologist…
This week, the Annals of Oncology published the “ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer”. This document results from a virtual consensus building process focused on non-small cell lung cancer (NSCLC) and EGFR…
